Literature DB >> 16199523

MLL associates specifically with a subset of transcriptionally active target genes.

Thomas A Milne1, Yali Dou, Mary Ellen Martin, Hugh W Brock, Robert G Roeder, Jay L Hess.   

Abstract

MLL (mixed-lineage leukemia) is a histone H3 Lys-4 specific methyltransferase that is a positive regulator of Hox expression. MLL rearrangements and amplification are common in acute lymphoid and myeloid leukemias and myelodysplastic disorders and are associated with abnormal up-regulation of Hox gene expression. Although MLL is expressed throughout hematopoiesis, Hox gene expression is sharply down-regulated during differentiation, suggesting that either the activity of MLL or its association with target promoters must be regulated. Here we show that MLL associates with actively transcribed genes but does not remain bound after transcriptional down-regulation. Surprisingly, MLL is associated not only with promoter regions but also is distributed across the entire coding regions of genes. MLL interacts with RNA polymerase II (pol II) and colocalizes with RNA pol II at a subset of actively transcribed target in vivo. Loss of function Mll results in defects in RNA pol II distribution. Together the results suggest that an intimate association between MLL and RNA pol II occurs at MLL target genes in vivo that is required for normal initiation and/or transcriptional elongation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199523      PMCID: PMC1253553          DOI: 10.1073/pnas.0503630102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein.

Authors:  P Ernst; J Wang; M Huang; R H Goodman; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation.

Authors:  Marco Birke; Silke Schreiner; María-Paz García-Cuéllar; Kerstin Mahr; Fritz Titgemeyer; Robert K Slany
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

3.  Dimerization of MLL fusion proteins immortalizes hematopoietic cells.

Authors:  Mary Ellen Martin; Thomas A Milne; Sebastien Bloyer; Karine Galoian; Weiping Shen; Denise Gibbs; Hugh W Brock; Robert Slany; Jay L Hess
Journal:  Cancer Cell       Date:  2003-09       Impact factor: 31.743

4.  Differential expression of Hox, Meis1, and Pbx1 genes in primitive cells throughout murine hematopoietic ontogeny.

Authors:  Nicolas Pineault; Cheryl D Helgason; H Jeffrey Lawrence; R Keith Humphries
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

5.  Upregulation of Meis1 and HoxA9 in acute lymphocytic leukemias with the t(4 : 11) abnormality.

Authors:  T Rozovskaia; E Feinstein; O Mor; R Foa; J Blechman; T Nakamura; C M Croce; G Cimino; E Canaani
Journal:  Oncogene       Date:  2001-02-15       Impact factor: 9.867

6.  MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.

Authors:  Scott A Armstrong; Jane E Staunton; Lewis B Silverman; Rob Pieters; Monique L den Boer; Mark D Minden; Stephen E Sallan; Eric S Lander; Todd R Golub; Stanley J Korsmeyer
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

7.  A homeotic mutation in the trithorax SET domain impedes histone binding.

Authors:  K R Katsani; J J Arredondo; A J Kal; C P Verrijzer
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

Review 8.  Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.

Authors:  P M Ayton; M L Cleary
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

Review 9.  The many faces of histone lysine methylation.

Authors:  Monika Lachner; Thomas Jenuwein
Journal:  Curr Opin Cell Biol       Date:  2002-06       Impact factor: 8.382

10.  The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex.

Authors:  J M Trimarchi; B Fairchild; J Wen; J A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

View more
  110 in total

1.  Charge-based interaction conserved within histone H3 lysine 4 (H3K4) methyltransferase complexes is needed for protein stability, histone methylation, and gene expression.

Authors:  Douglas P Mersman; Hai-Ning Du; Ian M Fingerman; Paul F South; Scott D Briggs
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

2.  ECSASB2 mediates MLL degradation during hematopoietic differentiation.

Authors:  Jingya Wang; Andrew G Muntean; Jay L Hess
Journal:  Blood       Date:  2011-12-15       Impact factor: 22.113

3.  Histone methyltransferase MLL1 regulates MDR1 transcription and chemoresistance.

Authors:  Hairong Huo; Pellegrino G Magro; E Christy Pietsch; Brijesh B Patel; Kathleen W Scotto
Journal:  Cancer Res       Date:  2010-09-22       Impact factor: 12.701

4.  Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.

Authors:  Jolanta Grembecka; Shihan He; Aibin Shi; Trupta Purohit; Andrew G Muntean; Roderick J Sorenson; Hollis D Showalter; Marcelo J Murai; Amalia M Belcher; Thomas Hartley; Jay L Hess; Tomasz Cierpicki
Journal:  Nat Chem Biol       Date:  2012-01-29       Impact factor: 15.040

5.  The role of menin in hematopoiesis.

Authors:  Ivan Maillard; Jay L Hess
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

6.  Chromatin control of gene expression: mixed-lineage leukemia methyltransferase SETs the stage for transcription.

Authors:  Robert K Slany
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

7.  Yng1 PHD finger binding to H3 trimethylated at K4 promotes NuA3 HAT activity at K14 of H3 and transcription at a subset of targeted ORFs.

Authors:  Sean D Taverna; Serge Ilin; Richard S Rogers; Jason C Tanny; Heather Lavender; Haitao Li; Lindsey Baker; John Boyle; Lauren P Blair; Brian T Chait; Dinshaw J Patel; John D Aitchison; Alan J Tackett; C David Allis
Journal:  Mol Cell       Date:  2006-12-08       Impact factor: 17.970

8.  Wdr82 is a C-terminal domain-binding protein that recruits the Setd1A Histone H3-Lys4 methyltransferase complex to transcription start sites of transcribed human genes.

Authors:  Jeong-Heon Lee; David G Skalnik
Journal:  Mol Cell Biol       Date:  2007-11-12       Impact factor: 4.272

9.  Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents.

Authors:  Cecily A Bennett; Amanda C Winters; Nisha N Barretto; Charles S Hemenway
Journal:  Leuk Res       Date:  2009-02-20       Impact factor: 3.156

10.  CXXC finger protein 1 restricts the Setd1A histone H3K4 methyltransferase complex to euchromatin.

Authors:  Courtney M Tate; Jeong-Heon Lee; David G Skalnik
Journal:  FEBS J       Date:  2009-11-27       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.